TABLE 2.

A comparison of AzBio scores by comorbid condition

	Pre‐Op AzBio score	Post‐Op AzBio score	Net benefit AzBio score
Study subgroup (n = 26)	12% (±14%)	30% (±12%)	18% (±12%)
No comorbidities (n = 7)	5% (±7%)	32% (±13%)	27% (±9%)
Cardiac condition (n = 9)	15% (±18%)	25% (±13%)	10% (±14%)
Otologic condition (n = 7)	15% (±17%)	28% (±16%)	13% (±10%)
Neurologic condition (n = 6)	11% (±21%)	25% (±13%)	14% (±17%)
Autoimmune condition (n = 9)	10% (±12%)	31% (±8%)	20% (±8%)
Cancer (n = 4)	27% (± 23%)	38% (± 6%)	11% (± 20%)
Renal condition (n = 3)	0%	21% (±18%)	21% (±18%)